Aprea Therapeutics, Inc. (APRE)

Nasdaq: APRE · Pharmaceutical Preparations · Doylestown, PA · filing with the SEC since 2019

Grade5.3

◀ Past 3.9● Present 5.1▶ Future 6.4

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.

Income statement, by fiscal year, newest first
Fiscal year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Report filed	Mar 16, 2026	Mar 25, 2025	Mar 26, 2024	Mar 30, 2023	Mar 15, 2022	Mar 16, 2021	Mar 27, 2020	·	·
Research and development	7,043,035	9,363,537	7,627,491	16,402,273	23,895,875	37,879,325	20,950,672	14,194,732	13,392,631
General and administrative	6,476,560	6,458,699	8,427,703	20,969,771	13,550,478	14,931,887	8,593,626	2,294,671	2,459,744
Total operating expenses	13,519,595	15,822,236	16,055,194	113,392,228	37,446,353	52,811,212	29,544,298	16,489,403	15,852,375
Operating income	-13,233,836	-14,319,655	-15,471,963	-113,392,228	-37,446,353	·	·	·	·
Interest income (expense), net	652,086	1,289,144	1,224,133	448,667	1,648	222,652	156,351	-182	-15
Other income (expense), net	634,267	1,360,944	1,185,207	730,201	319,050	-667,600	1,484,491	961,134	662,125
Income tax expense	0	0	0	0	0	0	0	0	0
Net income including non-controlling interests	-12,599,569	-12,958,711	-14,286,756	-112,662,027	-37,127,303	-53,478,812	-28,059,807	-15,528,269	-15,190,250
Net income	-12,599,569	-12,958,711	-14,286,756	-112,662,027	-37,127,303	-53,478,812	-28,059,807	-15,528,269	-15,190,250
Earnings per share, basic	-1.93	-2.35	-3.95	-67.99	-34.88^r	-50.61^r	-93.40^b	·	·
Earnings per share, diluted	-1.93	-2.35^r	-3.95	-67.99^r	-34.88^r	-50.61^r	-93.40^b	·	·
Earnings per share, basic and diluted	·	·	·	·	·	-50.60^b	-93.40^b	-269.00^b	-263.40^b
Weighted average shares, basic	6,538,722	5,509,921	3,617,607	1,657,055	1,064,325^r	1,056,681^r	300,124^b	·	·
Weighted average shares, diluted	6,538,722	5,509,921	3,617,607	1,657,055	1,064,325^r	1,056,681^r	300,124^b	·	·
Weighted average shares, basic and diluted	·	·	·	·	·	1,056,683^b	300,124^b	57,718^b	57,653^b

As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-20 reverse split of Feb 2023.A dot is a line not tagged for that period. ^r restated by the company in a later report; ^b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.

What each line is, and the XBRL concept behind it

Research and development spent on inventing what it sells next

us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
us-gaap:ResearchAndDevelopmentExpense

General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense

Total operating expenses the running costs togetherus-gaap:OperatingExpenses

Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss

Interest income (expense), net interest earned less interest paid, outside the businessus-gaap:InterestIncomeExpenseNonoperatingNet

Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense

Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit

Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss

Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss

Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic

Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted

Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted

Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic

Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted

SI Assistanton APRE · research, not advice